A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism

Journal of Endocrinological Investigation

Volumn 29, Issue 6, 2006, Pages 511-515

  Boudou, Philippe ^a,d   Ibrahim, F ^a   Cormier, C ^a   Sarfati, E ^b   Souberbielle, J C ^c  

^a Hôpitaux Cochin ^*  (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSERM   (France)

Author keywords

Parathyroid hormone; Primary hyperparathyroidism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; CREATININE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FRANCE; FREQUENCY ANALYSIS; HUMAN; HYPOCALCEMIA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; SYMPTOMATOLOGY; TUMOR VOLUME; VITAMIN BLOOD LEVEL;

EID: 33746662842     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344140     Document Type: Article

References (20)

1. Woodhouse NJ, Doyle FH, Joplin GF. Vitamin-D deficiency and primary hyperparathyroidism. Lancet 1971, 7: 283-6.
2. Lumb GA, Stanbury SW. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974, 56: 833-9.
3. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999, 107: 561-7.
4. Nordenstrom E, Westerdahl J, Lindergard B, Lindblom P, Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 2002, 26: 1463-7.
5. Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000, 85: 1054-8.
6. Rao DS, Agarwal G, Talpos GB, et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 2002, 17 (Suppl 2): N75-80.
7. Kantorovich V, Gacad MA, Seeger LL, Adams JS. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 3541-3.
8. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002, 17: N2-11.
9. Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC. Third- or second-generation PTH assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90: 6370-2.
10. Gao P, Scheibel S, D'Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001, 16: 605-14.
11. Inaba M, Nakatsuka K, Imananishi Y, et al. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second generation assay for parathyroid hormone. Clin Chem 2004, 50: 385-90.
12. Nordenstrom E, Westerdahl J, Bergenfelz A. Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism. World J Surg 2004, 28: 502-7.
13. Yamashita H, Noguchi S, Uchino S, et al. Vitamin D status in Japanese patients with hyperparathyroidism: seasonal changes and effect on clinical presentation. World J Surg 2002, 26: 937-41.
14. Moosgaard B, Vestergaard P, Heickendorff L, et al. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005, 63: 506-13.
15. Westerdahl J, Lindblom P, Valdemarsson S, Tibblin S, Bergenfelz A. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 2000, 135: 142-7.
16. Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 2004, 70: 114-9.
17. Rude RK. Magnesium deficiency in parathyroid function. In: Bilezikian JP, Marcus R, Levine M eds. The parathyroids. New York: Raven-Press. 1994, 829-42.
18. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001, 86: 1212-21.
19. Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005, 90: 2122-6.
20. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77: 204-10.